NovoCare and the Rise of Direct-to-Consumer Pha...

By Rene Pretorius

March 14, 2025

NovoCare Pharmacy has launched a direct-to-consumer pharmaceutical access program for Wegovy (semaglutide), offering the medication at $499 per month for uninsured...
Tackling the Tuberculosis Burden in Children: A Global Perspective
Dialysis Technology Innovations: Revolutionizing Patient Care with Portable S...
Rising Chronic Kidney Disease Burden: A Global Health Challenge from 1990 to ...
Cost Savings and Impact of Comprehensive Medication Management in Healthcare
AI Moral Decision-Making: Navigating the Complexities of Kidney Allocation De...
AI Kidney Disease Detection: Transforming Eye Screenings for Diabetic Patients
Hypertension in Young South African Adults
CKD Prevalence in HIV Patients on TDF: A Global Perspective
South Africa Launches Patient-Led Cancer Registry
Fabhalta C3 glomerulopathy treatment Gains EMA Endorsement as First Targeted ...
Zircaix: A Potential Breakthrough in Kidney Cancer Diagnosis
Personalized Cancer Vaccine in High-Risk Kidney Cancer Patients